Metraipolis › archive › dc_63cc0e59dbeb

Pancreatic cancer immunotherapy biomarkers: from traditional markers to multimodal integration and dynamic monitoring — Europe PMC PMID:41939911

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41939911
DOI
10.3389/fimmu.2026.1686658
License (as archived)
solo-consultazione
Archived
2026-11-04T04:40:49.778Z
SHA-256 of the archived text
2d1aab0ec864e83ebbc2281ce4a8c32b0e1505dcc986abfee3c8181642295602
Stable URL of this page
https://metraipolis.com/documento/dc_63cc0e59dbeb

How to cite

Pancreatic cancer immunotherapy biomarkers: from traditional markers to multimodal integration and dynamic monitoring — Europe PMC PMID:41939911 — Europe PMC (en), https://europepmc.org/article/MED/41939911 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_63cc0e59dbeb (Metraipolis archive dc_63cc0e59dbeb, sha256 2d1aab0ec864e83ebbc2281ce4a8c32b0e1505dcc986abfee3c8181642295602)
BibTeX
@misc{dc63cc0e59dbeb,
  title = {Pancreatic cancer immunotherapy biomarkers: from traditional markers to multimodal integration and dynamic monitoring — Europe PMC PMID:41939911},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41939911},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_63cc0e59dbeb; sha256 2d1aab0ec864e83ebbc2281ce4a8c32b0e1505dcc986abfee3c8181642295602},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41939911. Agents can read the archived copy with the MCP tool read_document.